H-1B & Green Card Salary Data and Market Analysis
Total Filings
All time (charts below use selected years)Median Salary
Across filings in selected periodFiling Growth
51 → 51 filings, FY2021 to FY2025 (latest year appears partial)Top Employers
Hiring This RoleSee all H-1B/PERM filings for this role →
| Employer | Filings | Median Salary | Salary Range | Approval Rate |
|---|---|---|---|---|
| SCIEGEN PHARMACEUTICALS, INC. | 32 | $73,700 | $62,000 - $130,160 | 93.8% |
| ASCENT PHARMACEUTICALS, INC. | 29 | $75,600 | $60,000 - $107,250 | 100.0% |
| APPCO PHARMA LLC | 17 | $75,000 | $60,000 - $98,000 | 100.0% |
| EVARIC PHARMACEUTICALS INC. | 15 | $72,000 | $63,100 - $101,693 | 93.3% |
| BACTOLAC PHARMACEUTICAL INC | 15 | $76,850 | $58,850 - $109,000 | 100.0% |
| AMBIOPHARM, INC. | 13 | $60,000 | $46,000 - $90,000 | 100.0% |
| NOVITIUM PHARMA LLC | 13 | $87,402 | $80,000 - $135,000 | 100.0% |
| AVA INC | 6 | $66,560 | $66,200 - $94,950 | 100.0% |
| AACE PHARMACEUTICALS INC | 5 | $78,374 | $66,000 - $100,225 | 100.0% |
| Nature's Value, Inc. | 5 | $64,000 | $64,000 - $65,000 | 100.0% |
| EXCELSIOR NUTRITION INC | 5 | $47,403 | $46,946 - $54,080 | 100.0% |
| INTERNASH GLOBAL SERVICES, LLC | 4 | $90,355 | $58,011 - $105,706 | 100.0% |
| Havix Group LLC | 4 | $65,000 | $56,160 - $71,000 | 100.0% |
| Winder Laboratories, LLC | 4 | $63,617 | $60,632 - $63,856 | 100.0% |
| BELCHER PHARMACEUTICAL | 4 | $69,275 | $60,000 - $82,118 | 100.0% |
| Experience Level | Filings | Median Salary | Salary Range |
|---|---|---|---|
| Unspecified | 253 | $69,500 | $41,704 - $135,000 |
| I | 12 | $60,680 | $37,169 - $72,000 |
| III | 3 | $64,344 | $64,334 - $90,000 |
| City | State | Filings | Median Salary |
|---|---|---|---|
| Hauppauge | NY | 63 | $72,000 |
| Central Islip | NY | 30 | $76,207 |
| Piscataway | NJ | 17 | $75,000 |
| East Windsor | NJ | 15 | $87,402 |
| Fairfield | NJ | 13 | $66,000 |
| North Augusta | SC | 11 | $60,000 |
| Coram | NY | 5 | $64,000 |
| Largo | FL | 5 | $74,256 |
| San Diego | CA | 5 | $71,110 |
| WILLOWBROOK | IL | 5 | $66,560 |
Across the 244,862 petitions we hold for the H-1B cap lottery as a whole, the I-129 filing records the beneficiary's actual pay alongside their country of birth, education and gender. A raw pay gap between two groups is mostly a statement about which jobs they hold — so each gap below is shown twice: as it looks raw, and again measured within the same job title. The second number is the one to read.
Gender is here as the control. Our decomposition of the H-1B gender pay gap found that gap is sorting almost entirely — it survives the correction at under a percent. Country of birth and education do not behave that way: part of each gap is job mix, and a real difference is still standing after the correction.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| India | 164,659 | $90,397 | -$2,288 | -$2,411 | — |
| China | 35,095 | $110,000 | +$17,315 | +$8,896 | 48.6% |
| Philippines | 1,863 | $64,000 | -$28,685 | -$594 | 97.9% |
60 other values (39,441 petitions) are not shown, because too few of their petitions sit in a job title big enough to compare within. Only a raw figure exists there — and a raw figure is the thing this table corrects, so ranking it beside these would mislead rather than inform.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| Master's degree | 102,816 | $91,104 | -$896 | -$262 | — |
| Bachelor's degree | 88,784 | $90,000 | -$2,000 | -$1,219 | 39.0% |
| Doctorate degree | 11,783 | $128,400 | +$36,400 | +$17,739 | 51.3% |
| Professional degree | 2,272 | $150,000 | +$58,000 | +$24,154 | 58.4% |
One other value (103 petitions) is not shown, because too few of its petitions sit in a job title big enough to compare within. Only a raw figure exists there — and a raw figure is the thing this table corrects, so ranking it beside these would mislead rather than inform.
| Group | Petitions | Median actual pay | Raw gap vs everyone | Within the same job title | Explained by job mix |
|---|---|---|---|---|---|
| Men | 164,128 | $93,891 | +$1,206 | -$361 | — |
| Women | 80,734 | $90,000 | -$2,685 | +$469 | — |
How to read this. The within-occupation figure compares people holding the same job title, weighted by how many petitions sit in each title. Titles encode seniority, so equal pay within a title does not rule out differences in reaching that title — the same limitation that applies to any controlled pay-gap number. Figures are base pay only: the I-129 reports prospective base compensation, with no equity or bonus, so this is not total compensation. Coverage is FY2021–FY2024 cap-subject H-1B lottery petitions that carry both a pay figure and a job title — a one-time FOIA snapshot, not a live feed. Aggregates only, with small counts suppressed. Source: I-129 petition data sourced from USCIS, obtained by Bloomberg.
These roles are variations of QUALITY CONTROL CHEMIST with different seniority levels.
| Role | Experience Level | Filings | Avg Salary |
|---|---|---|---|
| QUALITY CONTROL CHEMIST | Unspecified | 867 | $60,113 |
| Quality Control Chemist I | 25 | $54,475 | |
| QUALITY CONTROL CHEMIST III | 6 | $71,089 | |
| Quality Control Chemists | Unspecified | 3 | $54,760 |
| Quality Conrol Chemist | Unspecified | 1 | $53,872 |
| SR. QUALITY CONTROL CHEMISTS | 1 | $46,093 |
| Fiscal Year | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| 2021 | 51 | $68,000 | 98.0% |
| 2022 | 42 | $69,475 | 100.0% |
| 2023 | 47 | $66,560 | 95.7% |
| 2024 | 42 | $72,000 | 95.2% |
| 2025 | 51 | $64,350 | 98.0% |
| 2026 | 35 | $70,000 | 94.3% |
Compare how top companies pay for this role.
| Company | Filings | Median Salary | Approval Rate |
|---|---|---|---|
| SCIEGEN PHARMACEUTICALS, INC. | 32 | $73,700 | 93.8% |
| ASCENT PHARMACEUTICALS, INC. | 29 | $75,600 | 100.0% |
| APPCO PHARMA LLC | 17 | $75,000 | 100.0% |
| EVARIC PHARMACEUTICALS INC. | 15 | $72,000 | 93.3% |
| BACTOLAC PHARMACEUTICAL INC | 15 | $76,850 | 100.0% |